Leptin, an adipocyte-derived cytokine that is closely associated with obesity, has recently been shown to be involved in carcinogenesis and cancer progression. Integrins are the major adhesive molecules in mammalian cells and have been associated with metastasis of cancer cells. In this study, we found that leptin increased the migration and the expression of avb3 integrin in human chondrosarcoma cells. We also found that human chondrosarcoma tissues and chondrosarcoma cell lines had significant expression of the long form (OBRl) leptin receptor, which was higher than that in normal cartilage and human primary chondrocyte. Leptin-mediated migration and integrin upregulation were attenuated by OBRl receptor antisense oligonucleotide. Activations of insulin receptor substrate (IRS)-1, phosphatidylinositol 3-kinase (PI3K), Akt and nuclear factor-kB (NF-kB) pathways after leptin treatment were demonstrated, and leptin-induced expression of integrin and migration activity was inhibited by the specific inhibitor, small-interfering RNA and mutant of IRS-1, PI3K, Akt and NF-kB cascades. Taken together, our results indicated that leptin enhances the migration of chondrosarcoma cells by increasing avb3 integrin expression through the OBR1/ IRS-1/PI3K/Akt/NF-kB signal transduction pathway.
Introduction
Chondrosarcoma is the second most common malignancy of bone with a poor response to chemotherapy or radiation treatment currently used, making the management of chondrosarcomas a complicated challenge (1, 2) . Clinically, surgical resection remains the primary mode of therapy for chondrosarcoma. In the absence of an effective adjuvant therapy, this mesenchymal malignancy has a poor prognosis and therefore, it is important to explore a novel and adequate remedy (3) .
Since chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and distant metastasis (4, 5) . An approach to decreasing the ability of invasion and metastasis may facilitate the development of effective adjuvant therapy. The invasion of tumor cells is a complex, multistage process. To facilitate cell motility, invading cells need to change the cell-cell adhesion properties, rearrange the extracellular matrix environment, suppress anoikis and reorganize their cytoskeletons (6) . Integrins are a family of transmembrane adhesion receptors comprising 19a and 8b subunits that interact non-covalently to form up to 24 different heterodimeric receptors (7, 8) . The combination of different integrin subunits on the cell surface allows cells to recognize and respond to a variety of different extracellular matrix proteins including fibronectin, laminin, collagen and vitronectin (7, 8) . Activation and elevated expression of integrin-coupled signaling effectors have been implicated in the induction of a wide variety of human cancers, including those of the breast, colon, prostate and ovaries (9) . In addition, the expression of integrin has been shown to correlate with poor prognosis in cancers of the lung, pancreas and cutaneous melanoma (10) (11) (12) (13) (14) . Integrin has also been implicated in metastasis of lung, breast, bladder and colon cancers (15) (16) (17) .
Leptin, the product of the ob gene, is a 16 kDa non-glycosylated peptide hormone synthesized almost exclusively by adipocytes that regulates appetite and energy expenditure at the hypothalamic level (18) . However, it has become increasingly apparent that leptin has other direct effects on non-neural cells (19) . In recent years, the effect of leptin on tumorigenesis, angiogenesis and metastasis has received particular attention (20, 21) . Leptin receptors (OBR) are found in many tissues in several alternatively spliced forms (22, 23) . One form of the receptor, long form (OBRl), is highly expressed in the hypothalamus, whereas a short form (OBRs) is highly expressed in microvessels of the blood-brain barrier (22, 24) . Upon binding to OBRl, leptin activates janus kinase 2 (JAK2), which then initiates downstream signaling including members of the signal transducers and activators of transcription (STAT) family of transcription factors (25) . The leptin receptor, through the activation of JAK2, is able to phosphorylate insulin receptor substrate (IRS) proteins and induce the IRS-phosphatidylinositol 3-kinase (PI3K)-signaling pathway (26) .
In recent years, increased body weight has been shown to be associated with increased death rates for cancers at multiple specific sites (27) . Previous studies have consistently shown a positive association between adiposity and increased risk of cancer of the endometrium, kidney, colon and breast cancer in postmenopausal women (28) (29) (30) (31) . However, the expression of OBR in various cancers has not been fully investigated, and the precise role of leptin in the development and promotion of cancer remains unknown. We hypothesized that leptin might be capable of regulating the migration of chondrosarcoma cells and integrin expression. In this study, we found that leptin increased the migration and the expression of integrin in human chondrosarcoma cells. In addition, OBRl receptor, IRS-1, PI3K, Akt and nuclear factor-jB (NF-jB)-signaling pathways may be involved in increasing integrin expression and cell migration by leptin.
Materials and methods

Materials
Anti-mouse and anti-rabbit IgG-conjugated horseradish peroxidase, rabbit polyclonal antibodies specific for phosphotyrosine residues (PY20), p85, Akt, phospho-Akt (Ser473), IRS-1, IjB kinase (IKK), p-IjBa, IjBa, p65 and the small-interfering RNAs (siRNAs) against IRS-1 and control [negative control for experiments using targeted siRNA transfection; each consisted of a scrambled sequence that would not lead to the specific degradation of any Abbreviations: FBS, fetal bovine serum; IKK, IjB kinase; IRS, insulin receptor substrate; JAK2, janus kinase 2; mRNA, messenger RNA; NF-jB, nuclear factor-jB; ODN, Oligonucleotide; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; PDTC, pyrrolidine dithiocarbamate; PI3K, phosphatidylinositol 3-kinase; qPCR, quantitative real-time PCR; siRNA, small-interfering RNA; STAT, signal transducers and activators of transcription; TPCK, N a -tosylphenylalanyl-chloromethyl-ketone. . A selective avb3 integrin antagonist cyclic RGD (cyclo-RGDfV) peptide and the cyclic RAD (cyclo-RADfV) peptide were purchased from Peptides International (Louisville, KY). The recombinant human leptin was purchased from PeproTech (Rocky Hill, NJ). Mouse monoclonal antibody specific for avb3 integrin was purchased from Chemicon (Temecula, CA). The NF-jB luciferase plasmid was purchased from Stratagene (La Jolla, CA). The p85 (p85, deletion of 35 amino acids from residues 479-513 of p85) and Akt (Akt K179A) dominant-negative mutants were gifts from Dr W.M.Fu (National Taiwan University, Taipei, Taiwan). The IKKa(KM) and IKKb(KM) mutants were gifts from Dr H.Nakano (Juntendo University, Tokyo, Japan). pSV-b-galactosidase vector, luciferase assay kit was purchased from Promega (Madison, WI). All other chemicals were obtained from Sigma-Aldrich (St Louis, MO).
Cell culture
The human chondrosarcoma cell line (JJ012) was kindly provided by Dr Sean P Scully (University of Miami School of Medicine, Miami, FL). The human chondrosarcoma cell line (SW1353) was obtained from the American Type Culture Collection. The cells were cultured in Dulbecco's modified Eagle's medium/a-modified Eagle medium supplemented with 10% fetal bovine serum (FBS) and maintained at 37°C in a humidified atmosphere of 5% CO 2 .
Primary cultures of human chondrocytes were isolated from articular cartilage as described previously (32) after approval by the local ethics committee. The cells were grown in plastic cell culture dishes in 95% air-5% CO 2 with Dulbecco's modified Eagle's medium which was supplemented with 20 mM N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid and 10% heat-inactivated FBS, 2 mM glutamine, penicillin (100 U/ml) and streptomycin (100 lg/ml).
Patients and specimen preparation
Upon approval by the local ethics committee, specimens of tumor tissue or normal cartilage tissue were obtained from patients, who have been pathologically diagnosed with chondrosarcoma or knee osteoarthritis and have undergone surgical resection at the China Medical University Hospital. Tissue specimens were ground and then sonicated in a TRIzol kit. The mRNA level was analyzed using reverse transcription-polymerase chain reaction (PCR) analysis.
For primary cultures from human chondrosarcoma cells, the samples were cleaned of surrounding fat, connective tissue and blood vessels. Thereafter, tissue samples were minced into pieces using a razor blade. Minced samples were transferred into 50 ml Falcon tubes, spun down at 1000 r.p.m. for 5 min and rinsed twice with fresh phosphate-buffered saline (PBS). Digestion was performed with 1 mg collagenase II/ml PBS at 37°C for 50 min in a shaking water bath. Cell suspension was pipetted up and down at least twice during incubation. After digestion, pure FBS was added to a minimum concentration of 10% to inactivate the collagenase, followed by a centrifugation step as described above. Cells were then cultured in Dulbecco's modified Eagle's medium/a-modified Eagle medium supplemented with 10% FBS and maintained at 37°C in a humidified atmosphere of 5% CO 2 .
Migration assay
The migration assay was performed using Transwell (Costar, Corning Life Sciences, Acton, MA; pore size, 8 lm) in 24-well dishes. Before performing the migration assay, cells were pretreated for 30 min with different concentrations of inhibitors, including the Ly294002, Akt inhibitor, PDTC, TPCK or vehicle control (0.1% dimethyl sulfoxide). Approximately 1 Â 10 4 cells in 200 ll of serum-free medium were placed in the upper chamber, and 300 ll of the same medium containing leptin were placed in the lower chamber. The plates were incubated for 24 h at 37°C in 5% CO 2 and then cells then were fixed in 1% formaldehyde for 5 min and stained with 0.05% crystal violet in PBS for 15 min. Cells on the upper side of the filters were removed with cottontipped swabs, and the filters were washed with PBS. Cells on the underside of the filters were examined and counted under a microscope. Each clone was plated in triplicate in each experiment, and each experiment was repeated at least three times. The number of invading cells in each experiment was adjusted by the cell viability assay to correct for proliferation effects of the leptin treatment (corrected number of invading cells 5 counted number of invading cells/percentage of viable cells) (33) .
Flow cytometric analysis
Human chondrosarcoma cells were plated in six-well dishes. The cells were then washed with PBS and detached with trypsin at 37°C. Cells were fixed for 10 min in PBS containing 1% paraformaldehyde. After being rinsed in PBS, the cells were incubated with mouse anti-human antibody against integrin (1:100) for 1 h at 4°C. Cells were then washed again and incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit secondary IgG (1:100; Leinco Tec., St Louis, MO) for 45 min and analyzed by flow cytometry using FACS Calibur and CellQuest software (BD Biosciences, San Jose, CA).
Western blot analysis
The cellular lysates were prepared and proteins were then resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to Immobilon polyvinyldifluoride membranes. The blots were blocked with 4% bovine serum albumin for 1 h at room temperature and then probed with rabbit antihuman antibodies against p85, p-Akt, Akt, p-IKK, IKK, p-p65 or p65 (1:1000) for 1 h at room temperature. After three washes, the blots were subsequently incubated with a donkey anti-rabbit peroxidase-conjugated secondary antibody (1:1000) for 1 h at room temperature. The blots were visualized with enhanced chemiluminescence using Kodak X-OMAT LS film (Eastman Kodak, Rochester, NY). Quantitative data were obtained using a computing densitometer and ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Quantitative real-time PCR
The quantitative real-time PCR (qPCR) analysis was carried out using TaqmanÒ one-step PCR Master Mix (Applied Biosystems, Foster City CA). One hundred nanogram of total complementary DNA were added per 25 ll reaction with sequence-specific primers and TaqmanÒ probes. Sequences for all target gene primers and probes were purchased commercially (b-actin was used as internal control) (Applied Biosystems). Quantitative reverse transcriptase-PCR assays were carried out in triplicate on an ABI Prism 7900 sequence detection system. The cycling conditions were 10 min polymerase activation at 95°C followed by 40 cycles at 95°C for 15 s and 60°C for 60 s. The threshold was set above the non-template control background and within the linear phase of target gene amplification to calculate the number of cycles at which the transcript was detected (denoted as C T ).
Oligonucleotide transfection
Chondrosarcoma cells were cultured to confluence; the complete medium was replaced with OPTI-MEM containing the antisense phosphorothioate oligonucleotides (ODNs) (5 lg/ml) that had been preincubated with Lipofectamine 2000 (10 lg/ml) for 30 min. OPTI-MEM containing 20% fetal calf serum was added 4 h later. The cells were washed after 24 h incubation at 37°C. All ODNs were synthesized and high-pressure liquid chromatography purified by MDBio (Taipei, Taiwan). The sequences used are as follows: OBRl antisense ODN, AGACCGAGCGGGCGTTAA and missense ODN, AGCCCGCGCGAGTGTTCA (34) .
Reporter assay
The chondrosarcoma cells were transfected with reporter plasmid using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations. Twenty-four hours after transfection, the cells were treated with inhibitors for 30 min and then leptin or vehicle was then added for another 24 h. Cell extracts were then prepared, and luciferase and b-galactosidase activities were measured (33, 34) .
Statistics
For statistical evaluation, Mann-Whitney U-test for non-Gaussian parameters and Student's t-test for Gaussian parameters (including Bonferroni correction). The difference is significant if the P value is ,0.05.
Results
Leptin-directed chondrosarcoma cell migration involves avb3 integrin upregulation Leptin has been reported to stimulate migration and invasion of human cancer cells directionally (35) . The role of leptin in chondrosarcoma cell migration was examined using the Transwell assay with correction of leptin-induced proliferation effects on human chondrosarcoma cells (33) . Figure 1A and B shows that leptin enhanced the migration of human chondrosarcoma cells (JJ012 and SW1353 cells) in a dose-dependent manner. Previous studies have shown significant expression of integrins in human cancer cells (36, 37) . We therefore hypothesized that integrins may be involved in leptin-directed chondrosarcoma cell migration. Flow cytometry analysis showed that leptin induced the cell surface expression of avb3 integrin in JJ012 cells also in a dose-dependent manner ( Figure 1C ). To confirm this finding, expression of mRNAs for the integrins in response to leptin was analyzed by qPCR. Treatment of JJ012 and SW1353 cells with leptin (A and B) . JJ012 cells were incubated with leptin for 24 h, and the cell surface avb3 integrin was determined using flow cytometry (C). Cells were incubated with leptin for 24 h, and the mRNA levels of av and b3 integrin was determined using qPCR (D and E). Cells were pretreated with avb3 monoclonal antibody (3 and 10 lg/ml), cyclic RGD (100 nM) or cyclic RAD (100 nM) for 30 min followed by stimulation with leptin. The in vitro migration activity was measured after 24 h (F). Total RNA were extracted from normal cartilage (lines 1-2), primary chondrocyte (lines 3-4), chondrosarcoma patients (lines 5-6) or from chondrosarcoma cell lines (SW1353 and JJ012) and subjected to qPCR analysis for av and b3 integrin (G). Results are expressed as the mean ± SEM.
Ã P ,0.05 compared with control; #P ,0.05 compared with leptin-treated group.
S.-N.Yang et al. Leptin directs the migration of chondrosarcoma induced the mRNA expression of av and b3 integrins ( Figure 1D and E). On the other hand, treatment of cells with leptin for 24 h did not affect the mRNA expression of a2, a3, a5 and b1 by qPCR (supplementary Figure S1 is available at Carcinogenesis Online). Therefore, the avb3 integrin is more important in leptin-induced migration of human chondrosarcoma cells. Pretreatment of cells for 30 min with anti-avb3 monoclonal antibody (3, 10 lg/ml) markedly inhibited the leptin-induced cell migration ( Figure 1F ). The cyclic RGD peptide (cyclo-RGDfV) at low concentration has been reported to bind avb3 at high affinity and block its function effectively (37) . Treatment of cells with cyclic RGD but not cyclic RAD inhibited the leptin-induced migration of chondrosarcoma cells ( Figure 1F ). These data suggest that leptin-induced cancer migration may occur via activation of the avb3 integrin receptor. We next examined human chondrosarcoma patients for expression of av and b3 integrins using qPCR. Expression of mRNA levels of av and b3 integrins in chondrosarcoma patients ( Figure 1G , lines 5-6) and chondrosarcoma cell lines (SW1353 and JJ012) were significantly higher than those in normal cartilage ( Figure 1G , lines 1-2) and primary chondrocyte ( Figure 1G, lines  3-4) . Therefore, the expression of av and b3 integrins is implicated in cancer progression of human chondrosarcoma cells.
Involvement of OBRl receptor in leptin-mediated migration of chondrosarcoma cells
Leptin exerts their effects through interaction with specific leptin receptors (OBRl and OBRs) (22, 23) . However, little is known about the expression of OBRl and OBRs receptor in human chondrosarcoma cells. We examined human chondrosarcoma patients for the expression of the OBR receptor using qPCR. Expression of mRNA levels of OBRl in chondrosarcoma patients (Figure 2A, lines 9-16 ) and chondrosarcoma cell lines (SW1353 and JJ012) were significantly higher than those in normal cartilage (Figure 2A, lines 1-8) . On the other hand, the mRNA expression of OBRl also expressing high level in primary chondrosarcoma and chondrosarcoma cell lines (JJ012 and SW1353) were compared with those in primary chondrocyte cells ( Figure 2C ). However, expression of mRNA levels of OBRs in chondrosarcoma patients and chondrosarcoma cell lines were not significantly different from those in normal cartilage or primary chondrocyte ( Figure 2B and D) . In addition, primary chondrosarcomas and SW1353 or JJ012 cell lines were more migratory than normal chondrocyte ( Figure 2E) . Thus, expression of OBRl receptor was associated with a metastatic phenotype of chondrosarcoma cells. Transfection of SW1353 and JJ012 cells with OBRl antisense-ODN but not OBRl missense-ODN reduced the mRNA expression of OBRl (data not shown). On the other hand, transfection of OBRl antisense-ODN but not missense-ODN effectively inhibited the migration and avb3 upregulation of chondrosarcoma cells ( Figure 2F and G) . These data suggest that leptin/OBRl receptor interaction plays a key role in migration of chondrosarcoma cells.
The signaling pathways of IRS-1/PI3K, Akt are involved in the potentiating action of leptin stimulation Leptin's action by signaling via JAK2 and phosphorylation of STAT3 or other pathways such as IRS-1 and PI3K has been reported (26) . We then directly measured the phosphorylation of IRS-1 in response to leptin application by the analysis of phosphotyrosine level of IRS-1 immunoprecipitated with IRS-1 antibody. Figure 3A shows that treatment of JJ012 cells with leptin induced an increase of phosphorylation of IRS-1 in a time-dependent manner, beginning from 10 min after treatment. To further examine whether IRS-1 activation is involved in the signal transduction pathway leading to cell migration by leptin, the IRS-1 siRNA was used. IRS-1 siRNA specifically inhibited the expression of IRS-1 but not IRS-2, -3 and -4 (data not shown). Figure 3B -D also shows that leptin-induced cell migration and avb3 integrin upregulation were inhibited by IRS-1 siRNA. Therefore, IRS-1 is much more important in leptin-induced migration in chondrosarcoma cells. We next examined whether leptin can activate PI3K, a critical downstream target of IRS-1 (26) . Treatment of JJ012 cells with leptin for 10-120 min increased the phosphorylation of p85 subunit of PI3K, as assessed by the measurement of phosphotyrosine from immunoprecipitated lysates using p85 ( Figure 4A ). Akt phosphorylation in response to leptin was then measured. As shown in Figure 4A , treatment of JJ012 cells with leptin resulted in a time-dependent phosphorylation of Akt. Pretreatment of chondrosarcoma cells for 30 min with Ly294002 and Akt inhibitor or transfection with p85 and Akt mutant for 24 h markedly attenuated the leptin-induced cell migration and avb3 integrin upregulation ( Figure 4B and C) . These results indicate that the IRS-1/PI3K/Akt pathway is involved in leptin-induced migration of human chondrosarcoma cells.
NF-jB-signaling pathways is involved in leptin-mediated integrin upregulation and migration activity As previously mentioned, NF-jB activation is necessary for the migration and invasion of human cancer cells (38) . To examine whether NF-jB activation is involved in leptin-induced cancer migration, an NF-jB inhibitor, PDTC, was used. Figure 5A shows that chondrosarcoma cells pretreated with PDTC (10 lM) inhibited the leptininduced migration of chondrosarcoma cells. Furthermore, cells pretreated with TPCK (3 lM), an IjB protease inhibitor, also reduced leptin-induced migration of cancer cells ( Figure 5A ). In addition, treatment of cells with PDTC or TPCK also antagonized leptininduced expression of avb3 integrin ( Figure 5B ). Therefore, involvement of NF-jB pathway in leptin induced migration of chondrosarcoma cells. We further examined the upstream molecules involved in leptin-induced NF-jB activation. Stimulation of cells with leptin induced IKKa/b phosphorylation in a time-dependent manner ( Figure 5C ). Furthermore, transfection with IKKa or IKKb mutant markedly inhibited the leptin-induced cell migration ( Figure 5D ). These data suggest that IKKa/b activation is involved in leptin-induced migration activity of human chondrosarcoma cells. Treatment of chondrosarcoma cells with leptin also caused IjBa phosphorylation in a time-dependent manner ( Figure 5C ). Previous studies showed that p65 Ser 536 phosphorylation increases NF-jB transactivation (39) , and the antibody specific against phosphorylated p65 Ser 536 was employed to examine p65 phosphorylation. Treatment of cells with leptin for various time intervals resulted in p65 Ser 536 phosphorylation ( Figure 5C ). To directly determine NF-jB activation after leptin treatment, chondrosarcoma cells were transiently transfected with jB-luciferase as an indicator of NF-jB activation. As shown in Figure 5E , leptin treatment of chondrosarcoma cells for 24 h caused increase in jB-luciferase activity. In addition, Ly294002, Akt inhibitor, PDTC and TPCK reduced leptin-mediated NF-jB activity ( Figure 5E ). Moreover, cotransfection of cells with p85, Akt, IKKa and IKKb mutant also abolished leptin-induced NF-jB promoter activity ( Figure 5F ). Taken together, these data suggest that activation of OBRl Leptin directs the migration of chondrosarcoma receptor, IRS-1, PI3K and Akt pathway is required for leptin-induced NF-jB activation in chondrosarcoma cells.
Discussion
It is estimated that chondrosarcoma accounts for 3.6% of the annual incidence of all primary bone malignancies in USA, after multiple myeloma and osteogenic sarcoma (5) . The distant metastatic potential of chondrosarcoma has previously been reported (4, 5) . Patients who develop metastatic chondrosarcoma have poor prognosis (6) . Although past research has shown that leptin expression enhanced tumorigenesis and metastasis of human cancer cells, its role in chondrosarcoma invasion was not elucidated (19, 20) . This study shows for the first time that leptin mediates migration of human chondrosarcoma cells. One of the mechanisms underlying leptin-directed migration was transcriptional upregulation of avb3 integrin and activation of OBRl receptor, IRS-1, PI3K, Akt and NF-jB pathways.
The leptin receptor belongs to the cytokine receptor superfamily (22) . It has been reported that human cancer cells express OBRl and OBRs leptin receptors (29, 40) . However, the expression of the leptin receptor isoforms in human chondrosarcoma cells are mostly unknown. Using qPCR analysis, we found that primary chondrosarcoma cells and chondrosarcoma cell lines (SW1353 and JJ012) express both OBRl and OBRs receptor isoforms. In addition, the expression of mRNA levels of OBRl but not OBRs in chondrosarcoma patients and chondrosarcoma cell lines were significantly higher than those in normal cartilage and primary chondrocyte. Moreover, primary chondrosarcoma and SW1353 or JJ012 cell lines were more migratory than those in normal chondrocyte. Our data provided the evidence that the expression of OBRl receptor is associated with a metastatic phenotype of chondrosarcoma cells.
Integrins link the extracellular matrix to intracellular cytoskeletal structures and signaling molecules and are implicated in the regulation of a number of cellular processes, including adhesion, signaling, motility, survival, gene expression, growth and differentiation (7, 8) . Using flow cytometry analysis, we found that leptin increased avb3 integrin expression, which plays an important role during tumor metastasis. Furthermore, leptin also increased the mRNA levels of av and b3 but not of a2, a3, a5 and b1 integrins. In the present study, we used avb3 integrin antibody to determine the role of avb3 integrin and found that it inhibited leptin-induced cancer migration. This was further confirmed by the result that cyclic RGD but not cyclic RAD inhibited the enhancement of invasion activity by leptin, indicating the involvement of avb3 integrin in leptin-mediated induction of cancer migration.
Upon leptin binding, OBR1 activates JAK2, which in turn phosphorylates tyrosine residues in the receptor tails, leading to the recruitment and activation of STAT-3 (30) . The leptin receptor, through the activation of JAK2, is also able to phosphorylate IRS proteins and stimulate the IRS-PI3K-signaling pathway (30, 41) . Here, we used the IRS-1 siRNA to determine the role of IRS-1 and found that it inhibited leptin-induced migration and integrin upregulation, indicating the possible involvement of IRS-1 in leptin-induced cell migration in chondrosarcoma cells. It has been reported that leptin increases the association of tyrosine-phosphorylated IRS-1 with p85, the regulatory subunit of PI3K, via its Src homology 2 domains (42) . Pretreatment of leptin with PI3K inhibitor Ly294002 antagonized the increase in migration activity by leptin. This was further confirmed by the result that the dominant-negative mutant of p85 inhibited the enhancement of migration and avb3 integrin by leptin. PI3K activation leads to phosphorylation of phosphatidylinositides and then activates the downstream main target, Akt, which is important in regulating cell growth, differentiation, adhesion and inflammatory reactions (43) . In this study, we demonstrate that both leptin-induced migration and integrin expression were inhibited by the Akt inhibitor. Furthermore, the leptin-induced increase in migration activity was also blocked by a dominant-negative Akt mutant. The cytoplasmic serine kinase Akt was found to be activated by leptin in human chondrosarcoma cells. These results indicate the involvement of IRS-1/PI3K-dependent Akt activation in leptin-mediated migration and integrin upregulation.
The prognosis of patients with chondrosarcoma distant metastasis is generally considered very poor; hence, preventing human chondrosarcoma metastasis is an important issue nowadays. Our study observes that leptin increases the activity of avb3 integrin via the OBRl-, IRS1-, PI3K-, Akt-, IKKa/b-and NF-jB-dependent pathway and enhances migration of human chondrosarcoma cells. Furthermore, the discovery of leptin-mediated signaling pathway helps us understand the mechanism of human chondrosarcoma metastasis and may lead us to develop effective therapy in the future. 
